123266-63-7

Basic information

• Product Name: 2,3-DIHYDRO-1-BENZOFURAN-7-CARBONYL CHLORIDE
• Synonyms: 2,3-DIHYDRO-1-BENZOFURAN-7-CARBONYL CHLORIDE;BUTTPARK 97\04-62;2,3-Dihydrobenzo[b]furan-7-carbonyl chloride;7-Benzofurancarbonyl chloride, 2,3-dihydro- (9CI);2,3-Dihydro-1-benzofuran-7-carbonyl chloride, 7-(Chlorocarbonyl)-2,3-dihydrobenzo[b]furan;2,3-dihydrobenzofuran-7-carbonyl chloride;7-BENZOFURANCARBONYL CHLORIDE, 2,3-DIHYDRO
• CAS NO: 123266-63-7
• Molecular Formula: C₉H₇ClO₂
• Molecular Weight: 182.6
• Product Categories: ACIDHALIDE
• Mol File: 123266-63-7.mol

Chemical Properties

• Boiling Point: 299.8 °C at 760 mmHg
• Flash Point: 111.6 °C
• Appearance: /
• Density: 1.342 g/cm³
• Vapor Pressure: 0.00116mmHg at 25°C
• Refractive Index: 1.586
• CAS DataBase Reference: 2,3-DIHYDRO-1-BENZOFURAN-7-CARBONYL CHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-DIHYDRO-1-BENZOFURAN-7-CARBONYL CHLORIDE(123266-63-7)
• EPA Substance Registry System: 2,3-DIHYDRO-1-BENZOFURAN-7-CARBONYL CHLORIDE(123266-63-7)

Safety Data

• Hazard Codes: C
• Hazardous Substances Data: 123266-63-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2,3-Dihydro-1-benzofuran-7-carbonyl chloride is used as a key intermediate in the synthesis of various pharmaceuticals. Its reactive carbonyl chloride group allows for the formation of different chemical bonds, enabling the development of new drug molecules with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 2,3-Dihydro-1-benzofuran-7-carbonyl chloride serves as a valuable building block for the synthesis of agrochemicals. Its versatility in forming chemical bonds contributes to the development of new compounds with potential applications in agriculture, such as pesticides and herbicides.
Used in Organic Synthesis:
2,3-Dihydro-1-benzofuran-7-carbonyl chloride is used as a reagent in organic synthesis for the preparation of heterocyclic compounds. Its carbonyl chloride functionality facilitates the formation of various chemical bonds, making it a useful component in the synthesis of complex organic molecules.
Used in Medicinal Chemistry:
In medicinal chemistry, 2,3-Dihydro-1-benzofuran-7-carbonyl chloride is employed as a versatile building block for the development of new drug molecules. Its ability to form different chemical bonds allows for the exploration of novel chemical structures with potential therapeutic properties.

InChI:InChI=1/C9H7ClO2/c10-9(11)7-3-1-2-6-4-5-12-8(6)7/h1-3H,4-5H2

Upstream product

• 35700-40-4 2,3-dihydrobenzofuran-7-carboxylic acid 
• 496-16-2 2.3-dihydrobenzofuran 
• 13661-90-0 2-vinyloxy-benzoic acid methyl ester 
• 119-36-8 methyl salicylate 
• 79-37-8 oxalyl dichloride 
• 69-72-7 salicylic acid 
• 133844-95-8 2,3-dihydro-benzofuran-7-carboxylic acid methyl ester 
• 75855-24-2 2-Hydroxy-3-vinyl-benzoic acid methyl ester 

Downstream Products

• 133844-95-8 2,3-dihydro-benzofuran-7-carboxylic acid methyl ester 
• 149530-56-3 2,3-Dihydro-N-<4-(1,1-dimethylethyl)phenylmethyl>-N-methyl-7-benzofurancarboxamid 
• 90484-22-3 7-benzofuranylcarboxylic acid 
• 99517-45-0 methyl benzofuran-7-carboxylate 
• 883120-58-9 N-(2-(1H-pyrazol-1-yl)phenyl)-2,3-dihydrobenzofuran-7-carboxamide 
• 170730-06-0 1-(2,3-dihydrobenzofuran-7-yl)ethanone 

Relevant articles and documents

Vascular endothelial growth factor receptor inhibitor and preparation method and application thereof

The invention provides a vascular endothelial growth factor receptor inhibitor and a preparation method and application thereof, and relates to a quinoline or quinazoline derivative with a structure as shown in a formula (I), a pharmaceutical composition containing a compound as shown in the formula (I) and application of the compound in preparation of drugs for preventing or treating angiogenesis-related diseases, in particular to prevention or treatment of tumors related to protein tyrosine kinase. Each substituent in the formula (I) is the same as the definition in the specification.

Discovery of N-aryl-9-oxo-9H-fluorene-1-carboxamides as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure-activity relationships of the 9-oxo-9H-fluorene ring

As a continuation of our studies of apoptosis inducing 9-oxo-9H-fluorene-1-carboxamides as potential anticancer agents, we explored modification of the 9-oxo-9H-fluorene ring. SAR studies showed that most changes to the 9-oxo-9H-fluorene ring were not wel

NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS AND USES THEREOF

The present invention relates to compounds of formula (I), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, formula (I). wherein R1, R2, R3, R4, and L1 are defined in the specfication, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions. The present invention also relates to compounds of formula (II), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, formula (II). wherein R1a, R2a, Rx, and n are as defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.

NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS AND USES THEREOF

The present invention relates to compounds of formula (I), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, R3, and L1 are defined in the specfication, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions. The present invention also relates to compounds of formula (II), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1a, R2a and (Rx)n are as defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.

SUBSTITUTED BENZOYLAMINO-INDAN-2-CARBOXYLIC ACIDS AND RELATED COMPOUNDS

The present invention relates to A compound of the formula Ia wherein in any of its stereoisomers forms or a mixture of stereoisomeric forms in any ratio, or a physiologically acceptable salt thereof, wherein the substituents are as described herein. The inventive compounds have CXCR5 inhibitory activity are particularly useful in treating or preventing various inflammatory diseases, such as rheumatoid arthritis, multiple sclerosis, lupus, Crohn's Disease, associated with the modulation of the human CXCR5 receptor.

SUBSTITUTED N-ARYL-9-OXO-9H-FLUORENE-1-CARBOXAMIDES AND ANALOGS AS ACTIVATOR OF CASPASES AND INDUCERS OF APOPTOSIS

The present invention is directed to substituted N-aryl-9-oxo-9H-fluorene-1-carboxamides and analogs thereof, represented by the general Formula I: (I) wherein R1-R8, X and Ar are defined herein. The present invention also relates to the discovery that co

Quaternary ammonium compounds as tachykinin antagonists

The present invention provides a compound of formula (I) wherein R is phenyl, C3-C7cycloalkyl or heteroaryl, each of which being optionally benzo- or C3-C7cycloalkyl-fused and optionally substituted, including in the benzo- or C3-C7cycloalkyl-fused portion, by from 1 to 3 substituents each independently selected from C1-C4alkyl, fluoro(C1-C4)alkyl, C1-C4alkoxy, fluoro(C1-C4)alkoxy, phenoxy, C2-C4alkanoyl, halo, C1-C4alkoxycarbonyl, C3-C7cycloalkyl, —S(O)m(C1-C4alkyl), cyano, —NR2R3, —S(O)mNR2R3, —NR4(C1-C4alkanoyl) and —CONR2R3, or R is 2,3-dihydrobenzo[b]furanyl or chromanyl; R1is H or C1-C6alkyl; W is a direct link, methylene or ethylene; X is unbranched C2-C4alkylene; Y is phenyl, naphthyl, benzyl, pyridyl, thienyl or C3-C7cycloalkyl, each of which being optionally substituted by from 1 to 3 substituents each independently selected from C1-C4alkyl, fluoro(C1-C4)alkyl, C1-C4alkoxy, fluoro(C1-C4)alkoxy, halo and cyano; Ar is phenyl, naphthyl, benzyl, thienyl, benzo[b]thienyl or indolyl, each of which being optionally substituted by from 1 to 3 substituents each independently selected from C1-C4alkyl, fluoro(C1-C4)alkyl, C1-C4alkoxy, fluoro(C1-C4)alkoxy, halo and cyano, or Ar is 1,3-benzodioxolan-4 or 5-yl or 1,4-benzodioxan-5 or 6-yl; ZAis a pharmaceutically acceptable anion; with the proviso that when W is a direct link and R is optionally fused and optionally substituted heteroaryl, said heteroaryl is linked by a ring carbon atom to the carbonyl group. The compounds are tachykinin antagonists.

Synthesis and phosphodiesterase 5 inhibitory activity of novel phenyl ring modified sildenafil analogues

New sildenafil analogues containing an ether ring fused into the phenyl moiety, 6a-d and 7a-d, were efficiently synthesized from the readily available starting materials, 1a-d and 2, in five steps. Ab initio calculations indicated that introduction of a cyclic ether to the phenyl group might enhance the co-planarity of the molecule. The torsional angles were calculated to be 2-3° for the 5-membered cyclic ether derivatives, 6a, 6c, 7a, and 7c, and 12-16° for the 6-membered ones, 6b, 6d, 7b, and 7d. On the other hand, sildenafil showed the least co-planarity with the torsional angle of 23° compared with the target compounds, 6a-d and 7a-d. in the enzyme assay, however, the in vitro PDE 5 inhibitory activity was found out to be inversely related to the degree of co-planarity. In other words, the least planar sildenafil showed the highest actiivty, and the most planar 5-membered cyclic ether derivatives were least active by 100-200-fold compared with sildenafil. Our study clearly demonstrated that the open chain 2'-alkoxy group of the phenyl ring, although less effective for inducing the co-planarity, seemed to act as a much better lipophilic requirement than the cyclic alkoxy moiety. Copyright

Synthesis and properties of Biagra [1]. A 5-(2,3-dihydro-7-benzofuryl) analog of Viagra

The synthesis and spectral properties (IR, MS, NMR) of a substituted 5-(2,3-dihydro-7-benzofuryl)pyrazolo[4,3-d]pyrimidin-7-one (2), an analog of Viagra (1), are described. The generally applicable route involves interaction of 2,3-dihydro-7-benzofuranoyl chloride (3) with 4-amino-1-methyl-3-propyl-5-pyrazolecarboxamide (4), and the resulting bis-amide (5) is cyclized to the corresponding substituted pyrazolo[4,3-d]pyrimidin-7-one (6). Chlorosulfonylation of 6, followed by treatment with 1-methylpiperazine, furnished the title compound 2 (named Biagra). Preliminary experiments "associated with the erectile process" on rats lend evidence of greater potency of Biagra (2) as compared to Viagra (1).

Synthesis of new 7-benzofuranmethanamines as heterocyclic analogues of the squalenepoxidase-inhibitor Butenafine

Selected title compounds (6a-f, 7a-d) were synthesized by RedAl(R)-reduction of the carboxamides 4a-f and 5a-d, easily available from the corresponding (2,3-dihydro-)7-benzofurancarboxylic acids 1a-f or 2a-d, respectively. For practical reasons, the preparation of the 2,3-dihydro-2-methyl-7-benzofuranmethanamines 6h-k with varied N-substitution by alkylation of the N-methyl-benzofuranmethanamine 6g with preformed aralkylbromides 9a-d was preferred.